NeoGenomics, Inc. Inventory Write-down
NeoGenomics, Inc. (NEO) reported Inventory Write-down of $400.00 thousand for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-07-28
- NeoGenomics, Inc. inventory write-down for the quarter ending 2025-12-31 was $0.00.
- NeoGenomics, Inc. inventory write-down for the quarter ending 2025-09-30 was $0.00.
- NeoGenomics, Inc. inventory write-down for the quarter ending 2025-06-30 was $400.00K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-04-28 | $0.00 derived: sum of 2 quarters · filed 2026-04-28 | $400.00K derived: sum of 3 quarters · filed 2026-07-28 | $400.00K 10-Q · filed 2026-04-28 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $400.00K derived: sum of 2 quarters · filed 2026-07-28 | $400.00K 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $400.00K 10-Q · filed 2026-07-28 | $400.00K 10-Q · filed 2026-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |